819 articles
Returning guest, Daniel Simon, SVP, BioPharma Business Development at Guardant Health, a leading precision oncology company discusses a strategic collab...
Gary Lelli, Vice-Chair of Ophthalmology at Weill Cornell Medicine, discusses the Horizon Therapeutics and Prevent Blindness launch of FOCUS, an initiati...
Gwen Nichols, M.D., Chief Medical Officer at the Leukemia & Lymphoma Society discusses blood cancers, the progress in blood cancer therapies, and the im...
David Spetzler, President and Chief Scientific Officer at Caris® Life Sciences discusses partnering with Merus, a clinical-stage oncology company, to d...
Kathryn Lang, vice president of Health Outcomes and Evidence at Guardant Health discusses research highlighting the significance of its LUNAR-2 liquid b...
Steve Tilles, Senior Director of Medical Affairs at Aimmune Therapeutics, the first company to gain FDA approval of a peanut allergy treatment, PALFORZI...
Galderma's "Beyond the visible: rosacea and psoriasis of the face" is a global survey involving over 600 patients with facial skin disease (rosacea or p...
Carlos Doti discusses the results from two trials - Ph.2 ACE-CL-001 and Ph.3 ASCEND, that was presented at the virtual edition of the European Hematolog...
Roy Herbst, MD, of Yale Cancer Center and Smilow Cancer Hospital, discusses data presented at the American Society of Clinical Oncology (ASCO20) Virtual...
Oswald Peterson, diagnosed in early 2017 with stage 4 non-small cell lung cancer that had spread throughout his body shares his story and talks about th...